This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thursday's Small-Cap Winners & Losers

QMed (QMED) rose after the company received three contracts to operate Medicare Advantage Special Needs Plans and reiterated its 2007 revenue forecast for its QMedCare unit of between $38 million and $44.5 million. Shares of QMed were up 13.2% to $4.73.

United American Healthcare (UAHC) said its Health Plan of Tennessee unit received bid approval from the Centers for Medicare and Medicaid Services to act as a Medicare Advantage qualified organization beginning in 2007. United American was higher by 13.3% to $4.35.

Shares of Transmeta (TMTA) jumped 12% after Matrix Research initiated coverage of the company with a strong buy rating. Transmeta was recently adding 14 cents to $1.31.

Iris International (IRIS) jumped on news that its Iris Diagnostics division signed a five-year agreement to supply and service automated urine microscopy technology for LabCorp (LH). Shares of Iris were gaining 11.7% to $11.18.

American Mold Guard (AMGI) slumped after the company cut its third-quarter sales forecast. The company was expecting sales of $3.1 million to $3.6 million, but it now believes it will have $2.1 million to $2.3 million. American Mold Guard was losing 17% to $2.79.

Authentidate Holding (ADAT - Get Report) was lower following the company's fourth-quarter financial results. Revenue was about $3.7 million, down from $4.8 million a year ago. Authentidate narrowed its loss to $5.9 million, or 17 cents a share, from $8.4 million and 24 cents a share a year ago. The stock dropped 14.3% to $1.92.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AMGI $0.00 0.00%
QMED $0.00 0.00%
UAHC $0.03 0.00%
ADAT $0.31 0.00%
AAPL $123.25 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs